Voyager Therapeutics Financial Overview
Voyager Therapeutics's market cap is currently $226.85M. The company's EPS TTM is $-0.47; its P/E ratio is -1.88; Voyager Therapeutics is scheduled to report earnings on November 10, 2025, and the estimated EPS forecast is $-0.51. See an overview of income statement, balance sheet, and cash flow financials.
